RedHill Biopharma Ltd (ADR)
General ticker "RDHL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $48.3M
RedHill Biopharma Ltd (ADR) does not follow the US Stock Market performance with the rate: -37.4%.
Estimated limits based on current volatility of 3.7%: low 6.30$, high 6.78$
Factors to consider:
- Current price 64.2% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [56.25$, 341.16$]
- 2023-12-31 to 2024-12-30 estimated range: [17.63$, 94.96$]
Financial Metrics affecting the RDHL estimates:
- Negative: Non-GAAP EPS, $ of -508.97 <= 0.10
- Negative: Operating profit margin, % of -40.94 <= 1.03
- Negative: Operating cash flow per share per price, % of -7.46 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -15.82 <= 3.85
- Negative: Industry earnings per price (median), % of -20.11 <= 1.31
- Negative: Industry inventory ratio change (median), % of 3.13 > 0.49
Short-term RDHL quotes
Long-term RDHL plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $64.36MM | $85.76MM | $61.80MM |
| Operating Expenses | $128.04MM | $166.89MM | $104.64MM |
| Operating Income | $-63.68MM | $-81.14MM | $-42.84MM |
| Non-Operating Income | $-12.49MM | $-16.61MM | $-28.82MM |
| Interest Expense | $12.76MM | $16.57MM | $41.33MM |
| R&D Expense | $16.49MM | $29.50MM | $7.28MM |
| Income(Loss) | $-76.17MM | $-97.74MM | $-71.67MM |
| Taxes | $12.84MM | $16.57MM | $-12.42MM |
| Profit(Loss) | $-89.02MM | $-114.31MM | $-59.24MM |
| Stockholders Equity | $13.86MM | $8.88MM | $-48.40MM |
| Inventory | $6.53MM | $14.81MM | $11.01MM |
| Assets | $180.24MM | $181.19MM | $158.87MM |
| Operating Cash Flow | $-48.58MM | $-65.05MM | $-29.18MM |
| Capital expenditure | $53.77MM | $0.12MM | $0.20MM |
| Investing Cash Flow | $-35.65MM | $-8.14MM | $8.30MM |
| Financing Cash Flow | $84.37MM | $73.46MM | $11.45MM |
| Earnings Per Share* | $-97.75 | $-98.27 | $-38.27 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.